Table 2.
Relation between lncRNA-CIR expression and clinicopathological characteristics of osteosarcoma patients
| Characteristic | LncRNA-CIR | P | |
|---|---|---|---|
| Low expression | High expression | ||
| All case (n = 54) | 18 | 36 | |
| Age (year) | 0.569 | ||
| < 23 | 8 | 13 | |
| ≥ 23 | 10 | 23 | |
| Gender | 0.766 | ||
| Male | 11 | 24 | |
| Female | 7 | 12 | |
| Differentiation | 0.012 | ||
| Median/well | 10 | 7 | |
| Poor | 8 | 29 | |
| Tumor size (cm) | 0.766 | ||
| ≥ 3 | 7 | 12 | |
| < 3 | 11 | 24 | |
| Disease stage | 0.004 | ||
| IA | 3 | 2 | |
| IB | 3 | 2 | |
| IIA | 5 | 3 | |
| IIB | 5 | 5 | |
| III | 2 | 24 | |
| Distant metastasis | 0.008 | ||
| Yes | 5 | 25 | |
| No | 13 | 11 | |
Prognosis of patients was measured by Kaplan–Meier method and the classified variable was analyzed by Fisher’s exact test
lncRNA-CIR long non-coding RNA cartilage injury-related